Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
CF PharmTech. Inc. Class H
2652Health technology
$1.9B
Market Cap
Shariah Analysis
TBD
Business
Cash
Liabilities
Based on AAOIFI screening standards, CF PharmTech. Inc. Class H appears to be TBD.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)0.00%
Non-Shariah Cash Items
Cash And Cash Equivalents$81.9M
Other Short Term Investments$266.1M
Restricted Cash$5.1M
Liabilities (<30%)0.00%
Non-Shariah Liabilities
Current Capital Lease Obligation$2.4M
Long Term Debt$55.4M
Long Term Capital Lease Obligation$2.8M
Current Debt$18.5M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
